Lymphoma, leukemia, and other cancers that circulate in blood and lymph present unique opportunities for diagnosis, treatment, and drug development. In this course, you will consider the molecular origins of these liquid tumors.

Through the analysis of biomarkers and testing methodologies, you will examine how blood cancer classification guides treatment selection and monitoring. You'll explore innovative therapeutic strategies while discovering how rare cancer populations create distinct pathways for drug development and approval.

By the end of this course, you will be able to confidently discuss these specific cancers in clinical spaces and with other crucial stakeholder groups, such as in patient advocacy or research fields.

You are required to have completed the following courses or have equivalent experience before taking this course:

  • How Cancer Works
  • Cancer Genetics and Mutations
  • Cancer Treatment Fundamentals
  • Lung and Colon Cancer
  • Breast and Prostate Cancer
 

How It Works

Course Length
2 weeks

Effort
6 to 8 hours of study per week

Format
100% online, instructor-led
  • Biomedical engineers, physicists, chemists, and biologists seeking clinical expertise
  • Cancer researchers, patients, survivors, family members, and professionals who provide services or products for cancer intervention
  • Caregivers
  • Oncology nurses and cancer care specialists
  • Healthcare and biotech entrepreneurs
Get It Done 100% Online
Our programs are expressly designed to fit the lives of busy professionals like you.

Learn From cornell's Top Minds
Courses are personally developed by faculty experts to help you gain today's most in-demand skills.

Power Your career
Cornell's internationally recognized standard of excellence can set you apart.

Request Information Now by completing the form below.

Act today—courses are filling fast.